Company profile
Ayujoy Herbals Ltd.
OTC: AJOY · Healthcare · Medical - Pharmaceuticals
PublicHQ Mumbai, Reports USD
#1163 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ listing tenure, growth stability · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$136.4k
Employees
16
as of 2026-09-01
Market cap
$103.7k
as of 2026-09-01
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02023
Net income-$136.4k-$136.4k2023
Operating income-$65.1k-$65.1k2023
Total assets$2.9k$2.9k2023
Liabilities$64.8k$64.8k2023
Equity-$61.9k-$61.9k2023
Revenue trend
FY2013 – FY2023 · USD
FY13
FY14
FY15
FY16
FY17
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ayujoy Herbals Ltd.’s revenue?
Ayujoy Herbals Ltd. booked $0 in FY2023 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Immunotech Laboratories, Inc.——Drug Free Solution, Inc.——Link Reservations Inc.——NanoSphere Health Sciences Inc.——Many Bright Ideas Technologies Inc.——Priority Aviation, Inc.——Key facts
CEODipika Purohit
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersMumbai, null
ExchangeOTC: AJOY
Employees16
IPO date2012-03-14
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.